BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16507833)

  • 21. Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg?
    Wimmer K; Etzler J
    Hum Genet; 2008 Sep; 124(2):105-22. PubMed ID: 18709565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.
    Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN
    Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive deficiency in DNA mismatch repair.
    Felton KE; Gilchrist DM; Andrew SE
    Clin Genet; 2007 Jun; 71(6):483-98. PubMed ID: 17539897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PMS2 monoallelic mutation carriers: the known unknown.
    Goodenberger ML; Thomas BC; Riegert-Johnson D; Boland CR; Plon SE; Clendenning M; Win AK; Senter L; Lipkin SM; Stadler ZK; Macrae FA; Lynch HT; Weitzel JN; de la Chapelle A; Syngal S; Lynch P; Parry S; Jenkins MA; Gallinger S; Holter S; Aronson M; Newcomb PA; Burnett T; Le Marchand L; Pichurin P; Hampel H; Terdiman JP; Lu KH; Thibodeau S; Lindor NM
    Genet Med; 2016 Jan; 18(1):13-9. PubMed ID: 25856668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two PMS2 mutations in a Turcot syndrome family with small bowel cancers.
    Agostini M; Tibiletti MG; Lucci-Cordisco E; Chiaravalli A; Morreau H; Furlan D; Boccuto L; Pucciarelli S; Capella C; Boiocchi M; Viel A
    Am J Gastroenterol; 2005 Aug; 100(8):1886-91. PubMed ID: 16144131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diversity of the clinical presentation of the MMR gene biallelic mutations.
    Bougeard G; Olivier-Faivre L; Baert-Desurmont S; Tinat J; Martin C; Bouvignies E; Vasseur S; Huet F; Couillault G; Vabres P; Le Pessot F; Chapusot C; Malka D; Bressac-de Paillerets B; Tosi M; Frebourg T
    Fam Cancer; 2014 Mar; 13(1):131-5. PubMed ID: 24068316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pitfalls in the diagnosis of biallelic PMS2 mutations.
    Antelo M; Milito D; Rhees J; Roca E; Barugel M; Cuatrecasas M; Moreira L; Leoz ML; Carballal S; Ocaña T; Pellisé M; Castells A; Boland CR; Goel A; Balaguer F
    Fam Cancer; 2015 Sep; 14(3):411-4. PubMed ID: 25773960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A homozygous MSH6 mutation in a child with café-au-lait spots, oligodendroglioma and rectal cancer.
    Menko FH; Kaspers GL; Meijer GA; Claes K; van Hagen JM; Gille JJ
    Fam Cancer; 2004; 3(2):123-7. PubMed ID: 15340263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.
    Schafmayer C; Buch S; Egberts JH; Franke A; Brosch M; El Sharawy A; Conring M; Koschnick M; Schwiedernoch S; Katalinic A; Kremer B; Fölsch UR; Krawczak M; Fändrich F; Schreiber S; Tepel J; Hampe J
    Int J Cancer; 2007 Aug; 121(3):555-8. PubMed ID: 17417778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal Cancer due to Constitutional Mismatch Repair Deficiency Mimicking Neurofibromatosis I.
    Urganci N; Genc DB; Kose G; Onal Z; Vidin OO
    Pediatrics; 2015 Oct; 136(4):e1047-50. PubMed ID: 26391938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constitutional mismatch repair deficiency presenting in childhood as three simultaneous malignancies.
    Walter AW; Ennis S; Best H; Vaughn CP; Swensen JJ; Openshaw A; Gripp KW
    Pediatr Blood Cancer; 2013 Nov; 60(11):E135-6. PubMed ID: 23729388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of the DNA mismatch repair factor, PMS2, confers hypermutability and DNA damage tolerance.
    Gibson SL; Narayanan L; Hegan DC; Buermeyer AB; Liskay RM; Glazer PM
    Cancer Lett; 2006 Dec; 244(2):195-202. PubMed ID: 16426742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome.
    Ripperger T; Schlegelberger B
    Eur J Med Genet; 2016 Mar; 59(3):133-42. PubMed ID: 26743104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency.
    Chmara M; Wernstedt A; Wasag B; Peeters H; Renard M; Beert E; Brems H; Giner T; Bieber I; Hamm H; Sciot R; Wimmer K; Legius E
    Genes Chromosomes Cancer; 2013 Jul; 52(7):656-64. PubMed ID: 23629955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common variants in mismatch repair genes and risk of invasive ovarian cancer.
    Song H; Ramus SJ; Quaye L; DiCioccio RA; Tyrer J; Lomas E; Shadforth D; Hogdall E; Hogdall C; McGuire V; Whittemore AS; Easton DF; Ponder BA; Kjaer SK; Pharoah PD; Gayther SA
    Carcinogenesis; 2006 Nov; 27(11):2235-42. PubMed ID: 16774946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extensive gene conversion at the PMS2 DNA mismatch repair locus.
    Hayward BE; De Vos M; Valleley EM; Charlton RS; Taylor GR; Sheridan E; Bonthron DT
    Hum Mutat; 2007 May; 28(5):424-30. PubMed ID: 17253626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent and founder mutations in the PMS2 gene.
    Tomsic J; Senter L; Liyanarachchi S; Clendenning M; Vaughn CP; Jenkins MA; Hopper JL; Young J; Samowitz W; de la Chapelle A
    Clin Genet; 2013 Mar; 83(3):238-43. PubMed ID: 22577899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.